[F:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]1[CH:10]=[C:11]([CH:15]=[C:16]([C:18]([OH:21])([CH3:20])[CH3:19])[N:17]=1)[C:12]([OH:14])=O.[O-:22][N+:23]1[C:28]([C:29]([F:32])([F:31])[F:30])=[CH:27][CH:26]=[C:25]([C@H:33]([NH2:35])[CH3:34])[CH:24]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)CC)(C)C.FC(F)(F)C(O)=O>CN(C=O)C.O>[F:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]1[CH:10]=[C:11]([CH:15]=[C:16]([C:18]([OH:21])([CH3:20])[CH3:19])[N:17]=1)[C:12]([NH:35][C@@H:33]([C:25]1[CH:24]=[N+:23]([O-:22])[C:28]([C:29]([F:30])([F:31])[F:32])=[CH:27][CH:26]=1)[CH3:34])=[O:14]To a solution of 2-(2,4-difluorophenyl)-6-(1-hydroxy-1-methylethyl)isonicotinic acid (19.5 mg, 0.07 mmol) in DMF (0.67 mL) were added hydrochloride salt of (1R)-1-[1-oxido-6-(trifluoromethyl)pyridin-3-yl]ethanamine (24.2 mg, 0.10 mmol), HATU (0.5 M in DMA; 0.2 mL, 0.10 mmol) and diisopropylethylamine (46.5 uL, 0.27 mmol). The mixture was stirred at ambient temperature. After 30 min, small amount of water and trifluoroacetic acid were added and the mixture was purified by reverse phase chromatography (C-18, 95% water/acetonitrile→5% water/acetonitrile with 0.1% trifluoroacetic acid) gave the title compound (28 mg). HRMS 482.1462 (M+1). 1H NMR (400 MHz, CDCl3): δ 8.38 (s, 1H); 8.09-8.01 (m, 1H); 7.94 (s, 1H); 7.73 (s, 1H); 7.67 (d, J=8.3 Hz, 1H); 7.38 (d, J=8.3 Hz, 1H); 7.07-6.98 (m, 1H); 6.99-6.90 (m, 1H); 6.74 (d, J=6.9 Hz, 1H); 5.32-5.25 (m, 1H); 4.38 (s, 1H); 1.67 (d, J=7.1 Hz, 3H); 1.62 (s, 6H).
読み込み中…